Termination mechanism of CREB-dependent activation of COX-2 expression in early phase of adipogenesis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Adipogenesis, the process of fat cell formation, is tightly regulated by complex molecular signaling pathways.
• Prostaglandins (PGs) are known to influence adipogenesis, but the precise molecular mechanisms, particularly concerning early-phase regulation, require further elucidation.
• Cyclooxygenase-2 (COX-2) plays a role in prostaglandin synthesis and has been implicated in adipogenesis, though its regulatory role in the early stages is not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanism by which prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) suppress the early phase of adipogenesis.
• To investigate the role of cyclooxygenase-2 (COX-2) expression in this suppressive process.
• To identify the key signaling molecules and transcription factors involved in regulating COX-2 expression during adipogenesis.

Main Methods:

• Utilized 3T3-L1 cells, a standard model for adipogenesis research.
• Employed 3-isobutyl-1-methylxanthine (IBMX) to inhibit phosphodiesterase and enhance protein kinase A (PKA) activity.
• Used dibutyryl cAMP to activate PKA and investigated the phosphorylation of cAMP response element-binding protein (CREB).
• Assessed CREB binding to the COX-2 promoter using techniques like siRNA to suppress CREB expression.
• Investigated the role of protein phosphatase 1/2A (PP1/2A) using okadaic acid, a specific inhibitor.

Main Results:

• Enhanced protein kinase A (PKA) activity, induced by IBMX and dibutyryl cAMP, led to increased phosphorylation of cAMP response element-binding protein (CREB).
• Phosphorylated CREB showed enhanced binding to the cAMP response element (CRE) in the COX-2 promoter, upregulating COX-2 gene expression.
• Suppression of CREB using siRNA significantly reduced COX-2 gene expression.
• Inhibition of protein phosphatase 1/2A (PP1/2A) by okadaic acid suppressed adipogenesis progression by preventing the suppression of CREB-dependent COX-2 expression, leading to increased production of anti-adipogenic PGs (PGE2 and PGF2α).

Conclusions:

• The study identifies a critical molecular pathway involving CREB-dependent COX-2 expression in the regulation of early adipogenesis.
• This pathway leads to the production of anti-adipogenic prostaglandins (PGE2 and PGF2α), thereby suppressing adipocyte differentiation.
• These findings highlight the intricate role of PGs and their regulatory mechanisms in controlling fat cell formation.